Cancer Cell Cycles

Uncontrolled cell proliferation is the hallmark of cancer, and tumor cells have typically acquired damage to genes that directly regulate their cell cycles. Genetic alterations affecting p16INK4a and cyclin D1, proteins that govern phosphorylation of the retinoblastoma protein (RB) and control exit from the G1 phase of the cell cycle, are so frequent in human cancers that inactivation of this pathway may well be necessary for tumor development. Like the tumor suppressor protein p53, components of this “RB pathway,” although not essential for the cell cycle per se, may participate in checkpoint functions that regulate homeostatic tissue renewal throughout life.

[1]  B. Stewart On Systematic Sun-Spot Periodicity , 1880, Nature.

[2]  John Griffith British Place-names in their Historical Setting , 1910, Nature.

[3]  G. W. Bohn,et al.  IMMUNITY TO FUSARIUM WILT IN THE TOMATO. , 1939, Science.

[4]  A. Knudson Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Kessin Mutations causing rapid development of Dictyostelium discoideum , 1977, Cell.

[6]  D. J. Mcfarland Decision making in animals , 1977, Nature.

[7]  E. Ashby Social impact of technology , 1978, Nature.

[8]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[9]  G. Steele,et al.  Cancer: Principles and Practice of Oncology , 1983 .

[10]  Comprehensive textbook of oncology , 1986 .

[11]  A. Pardee G1 events and regulation of cell proliferation. , 1989, Science.

[12]  C. Bréchot,et al.  Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma , 1990, Nature.

[13]  W. Bray Colour consciousness in archaeology , 1990, Nature.

[14]  A. Kimchi,et al.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.

[15]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[16]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[17]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[18]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[19]  R. Weinberg,et al.  Effects of an Rb mutation in the mouse , 1992, Nature.

[20]  M. Kastan,et al.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Murray,et al.  Creative blocks: cell-cycle checkpoints and feedback controls , 1992, Nature.

[22]  J. Nevins,et al.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[23]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[24]  G. Wahl,et al.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.

[25]  R. Weinberg,et al.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.

[26]  A. Bradley,et al.  Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.

[27]  A. Berns,et al.  Requirement for a functional Rb-1 gene in murine development , 1992, Nature.

[28]  S. Weintraub,et al.  Retinoblastoma protein switches the E2F site from positive to negative element , 1992, Nature.

[29]  R. Pepperkok,et al.  Cyclin A is required at two points in the human cell cycle. , 1992, The EMBO journal.

[30]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[31]  Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. , 1992, Molecular and cellular biology.

[32]  S. Reed,et al.  The role of p34 kinases in the G1 to S-phase transition. , 1992, Annual review of cell biology.

[33]  P. Nurse,et al.  Animal cell cycles and their control. , 1992, Annual review of biochemistry.

[34]  P. Shaw,et al.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Thea D. Tlsty,et al.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.

[36]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[37]  C. Purdie,et al.  Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.

[38]  Pengcheng Zhou,et al.  Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. , 1993, Oncogene.

[39]  L. Donehower,et al.  In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. , 1993, Oncogene.

[40]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[41]  David M. Livingston,et al.  Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.

[42]  S. Shurtleff,et al.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.

[43]  James M. Roberts,et al.  A link between cyclin A expression and adhesion-dependent cell cycle progression. , 1993, Science.

[44]  M. Pagano,et al.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1. , 1993, Genes & development.

[45]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[46]  E. Lam,et al.  An E2F‐binding site mediates cell‐cycle regulated repression of mouse B‐myb transcription. , 1993, The EMBO journal.

[47]  M. Ewen,et al.  Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. , 1993, Genes & development.

[48]  E. White,et al.  Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.

[49]  C. Turck,et al.  Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.

[50]  M. Solomon,et al.  Activation of the various cyclin/cdc2 protein kinases. , 1993, Current opinion in cell biology.

[51]  K. Helin,et al.  The retinoblastoma protein as a transcriptional repressor. , 1993, Trends in cell biology.

[52]  S. Lowe,et al.  Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.

[53]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.

[54]  James M. Roberts,et al.  Cyclin-dependent regulation of G1 in mammalian fibroblasts. , 1993, Science.

[55]  K Nasmyth,et al.  Control of the yeast cell cycle by the Cdc28 protein kinase. , 1993, Current opinion in cell biology.

[56]  Bert Vogelstein,et al.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.

[57]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[58]  A. Levine,et al.  p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Bartek,et al.  DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1 , 1994, The Journal of cell biology.

[60]  T. Graeber,et al.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.

[61]  L. M. Facchini,et al.  Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. , 1994, Oncogene.

[62]  W. Kaelin,et al.  Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[63]  H. Hermeking,et al.  Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.

[64]  A. Levine,et al.  Functions of the p53 protein in growth regulation and tumor suppression. , 1994, Cold Spring Harbor symposia on quantitative biology.

[65]  J. Massagué,et al.  Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27 Kip1 ) of cyclin-dependent kinase 4 activation , 1994, Cell.

[66]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[67]  James M. Roberts,et al.  Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.

[68]  E. Lam,et al.  DP and E2F proteins: coordinating transcription with cell cycle progression. , 1994, Current opinion in cell biology.

[69]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[70]  E. Lees,et al.  Cyclin E, a potential prognostic marker for breast cancer. , 1994, Cancer research.

[71]  Kathleen R. Cho,et al.  p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Nevins,et al.  Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. , 1994, Genes & development.

[73]  R. Weinberg,et al.  Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. , 1994, Genes & development.

[74]  S. Elledge,et al.  Cdk inhibitors: on the threshold of checkpoints and development. , 1994, Current opinion in cell biology.

[75]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[76]  D. Carson,et al.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.

[77]  John Calvin Reed,et al.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. , 1994, Oncogene.

[78]  M. Pagano,et al.  Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. , 1994, Oncogene.

[79]  W. Lee,et al.  Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis , 1994, Molecular and cellular biology.

[80]  B. Dynlacht,et al.  Differential regulation of E2F transactivation by cyclin/cdk2 complexes. , 1994, Genes & development.

[81]  D. Albert,et al.  Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. , 1994, Genes & development.

[82]  A. Abbott Rome "could host European mouse laboratory" , 1994, Nature.

[83]  Van Dyke Ta,et al.  Analysis of viral-host protein interactions and tumorigenesis in transgenic mice. , 1994 .

[84]  S. Lowe,et al.  p53-Dependent apoptosis suppresses tumor growth and progression in vivo , 1994, Cell.

[85]  C. O'keefe,et al.  Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. , 1994, Genes & development.

[86]  J. R. Smith,et al.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.

[87]  James M. Roberts,et al.  lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin , 1994, Nature.

[88]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[89]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[90]  DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. , 1994, Molecular and cellular biology.

[91]  R. Weinberg,et al.  Extensive contribution of Rb‐deficient cells to adult chimeric mice with limited histopathological consequences. , 1994, The EMBO journal.

[92]  Gregory J. Hannon,et al.  pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.

[93]  C. Sherr G1 phase progression: Cycling on cue , 1994, Cell.

[94]  R Montesano,et al.  Database of p53 gene somatic mutations in human tumors and cell lines. , 1994, Nucleic acids research.

[95]  James M. Roberts,et al.  Rules to replicate by , 1994, Cell.

[96]  M. Gossen,et al.  Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. , 1994, Molecular and cellular biology.

[97]  J.M. Adams,et al.  Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.

[98]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[99]  G. Demers,et al.  Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[100]  R. Weinberg,et al.  Growth suppression by p16ink4 requires functional retinoblastoma protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[101]  G. Stark,et al.  The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. , 1995, Trends in biochemical sciences.

[102]  B. Dynlacht,et al.  Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition , 1995, Nature.

[103]  J. Massagué,et al.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[104]  C. Norbury,et al.  Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. , 1995, Trends in biochemical sciences.

[105]  R. DePinho,et al.  Inhibition of ras-induced proliferation and cellular transformation by p16INK4 , 1995, Science.

[106]  S. Weintraub,et al.  Mechanism of active transcriptional repression by the retinoblastoma protein , 1995, Nature.

[107]  M. Roussel,et al.  Rescue of defective mitogenic signaling by D-type cyclins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[108]  R. Berger,et al.  A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. , 1995, Oncogene.

[109]  L. Sandkuijl,et al.  Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds , 1995, Nature Genetics.

[110]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[111]  H. Yokozaki,et al.  Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas , 1995, Japanese journal of cancer research : Gann.

[112]  J. Bartek,et al.  Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity , 1995, Molecular and cellular biology.

[113]  F. Zindy,et al.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.

[114]  S. Elledge,et al.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[115]  H. Yokozaki,et al.  Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas , 1995, International journal of cancer.

[116]  D N Shapiro,et al.  Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4 , 1995, Molecular and cellular biology.

[117]  A. Schulze,et al.  Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[118]  M. Pagano,et al.  Identification of a Myc‐dependent step during the formation of active G1 cyclin‐cdk complexes. , 1995, The EMBO journal.

[119]  J. Bartek,et al.  Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 , 1995, Nature.

[120]  M. Roussel,et al.  Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 , 1995, Molecular and cellular biology.

[121]  D. Conte,et al.  Deregulation of cyclin E in breast cancer. , 1995, Oncogene.

[122]  M. Serrano,et al.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.

[123]  W. Sellers,et al.  Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter , 1994, Molecular and cellular biology.

[124]  C. D. Edwards,et al.  A novel p16INK4A transcript. , 1995, Cancer research.

[125]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[126]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[127]  James Brugarolas,et al.  Radiation-induced cell cycle arrest compromised by p21 deficiency , 1995, Nature.

[128]  G. Stamp,et al.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. , 1995, Genes & development.

[129]  E. Nigg,et al.  Cyclin‐dependent protein kinases: Key regulators of the eukaryotic cell cycle , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[130]  R. Kerkhoven,et al.  Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. , 1995, Genes & development.

[131]  J. Nevins,et al.  Regulation of the cyclin E gene by transcription factor E2F1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[132]  D. Livingston,et al.  Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint , 1995, Cell.

[133]  P. O’Farrell,et al.  Developmental control of the G1 to S transition in Drosophila: cyclin Eis a limiting downstream target of E2F. , 1995, Genes & development.

[134]  E. White,et al.  Life, death, and the pursuit of apoptosis. , 1996, Genes & development.

[135]  Nobuyuki Shishido,et al.  Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.

[136]  B. Stillman,et al.  Cell Cycle Control of DNA Replication , 1996, Science.

[137]  G. Peters,et al.  Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence , 1996, Molecular and cellular biology.

[138]  S. Reed,et al.  Activation of cyclin E/CDK2 is coupled to site‐specific autophosphorylation and ubiquitin‐dependent degradation of cyclin E. , 1996, The EMBO journal.

[139]  N. Dyson,et al.  Ectopic expression of dE2F and dDP induces cell proliferation and death in the Drosophila eye. , 1996, The EMBO journal.

[140]  G. Woude,et al.  Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.

[141]  R. M. Böhmer,et al.  Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. , 1996, Molecular biology of the cell.

[142]  A. Hatzigeorgiou,et al.  Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter , 1996, Molecular and cellular biology.

[143]  T. Jacks,et al.  Targeted disruption of p107: functional overlap between p107 and Rb. , 1996, Genes & development.

[144]  James M. Roberts,et al.  Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. , 1996, Genes & development.

[145]  S. Orkin,et al.  The transcriptional control of hematopoiesis. , 1996, Blood.

[146]  K. Manova-Todorova,et al.  Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.

[147]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[148]  K. Palucka,et al.  Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage. , 1996, Blood.

[149]  R. Weinberg,et al.  Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts , 1996, Molecular and cellular biology.

[150]  A. Schulze,et al.  Copyright � 1996, American Society for Microbiology Anchorage-Dependent Transcription of the Cyclin A Gene , 1996 .

[151]  J. Nevins,et al.  Ectopic E2F expression induces S phase and apoptosis in Drosophila imaginal discs. , 1996, Genes & development.

[152]  D. Beach,et al.  Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.

[153]  R. Weinberg,et al.  Shared role of the pRB-related p130 and p107 proteins in limb development. , 1996, Genes & development.

[154]  James M. Roberts,et al.  Requirement of p27Kip1 for Restriction Point Control of the Fibroblast Cell Cycle , 1996, Science.

[155]  G. Peters,et al.  Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. , 1996, Advances in cancer research.

[156]  J. Bartek,et al.  Abrogation of p27Kip1 by cDNA Antisense Suppresses Quiescence (G0 State) in Fibroblasts* , 1996, The Journal of Biological Chemistry.

[157]  J. S. Kang,et al.  Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events , 1996, Molecular and cellular biology.

[158]  R. Kerr Ice Rhythms—Core Reveals a Plethora of Climate Cycles , 1996, Science.

[159]  James M. Roberts,et al.  A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.

[160]  T. Hunter,et al.  Dependence of Cyclin E-CDK2 Kinase Activity on Cell Anchorage , 1996, Science.

[161]  R. Kolodner,et al.  Biochemistry and genetics of eukaryotic mismatch repair. , 1996, Genes & development.

[162]  P. Nurse,et al.  Regulating S Phase: CDKs, Licensing and Proteolysis , 1996, Cell.

[163]  M. Ewen,et al.  Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[164]  R. Weinberg,et al.  Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. , 1996, Oncogene.

[165]  M. Greenberg,et al.  E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation , 1996, Cell.

[166]  W. B. Smith,et al.  A Role for Endothelial NO Synthase in LTP Revealed by Adenovirus-Mediated Inhibition and Rescue , 1996, Science.

[167]  W. J. Pledger,et al.  Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells , 1996, Molecular and cellular biology.

[168]  L. Hengst,et al.  Translational Control of p27Kip1 Accumulation During the Cell Cycle , 1996, Science.